PPI start
Initial dosing and step-down approach for gastroesophageal reflux.
Last reviewed January 5, 2026
Contraindications
- Avoid in known proton pump inhibitor hypersensitivity.
- Investigate alarm features before prolonged empiric therapy.
- Avoid indefinite continuation without a clear ongoing indication.
Dosing
Omeprazole
- Starting dose
- 20 mg once daily before breakfast
- Typical titration / target
- Increase to 20 mg twice daily if needed
- Monitoring / notes
- Reassess after 4-8 weeks and step down when controlled.
Pantoprazole
- Starting dose
- 40 mg once daily before breakfast
- Typical titration / target
- Increase to 40 mg twice daily if needed
- Monitoring / notes
- Review for alarm symptoms or inadequate response.
| Medication (generic) | Starting dose | Typical titration / target | Monitoring / notes |
|---|---|---|---|
| Omeprazole | 20 mg once daily before breakfast | Increase to 20 mg twice daily if needed | Reassess after 4-8 weeks and step down when controlled. |
| Pantoprazole | 40 mg once daily before breakfast | Increase to 40 mg twice daily if needed | Review for alarm symptoms or inadequate response. |
Renal and hepatic considerations
- In significant hepatic impairment, consider conservative dosing and closer review.
- Monitor for renal adverse-effect signals when treatment becomes prolonged.
- Reconcile drug-interaction risks before dose escalation.
Pregnancy and lactation cautions
- Confirm medication need and select pregnancy/lactation-compatible strategy.
- Use the lowest effective dose for the shortest necessary interval.
- Reassess ongoing need as clinical status changes.
Monitoring checkpoints
- Reassess response after 4-8 weeks and step down when controlled.
- Combine with lifestyle changes (weight loss, avoid late meals).
- Consider H. pylori testing if dyspepsia is prominent.
Stop or escalate criteria
- Step down or stop when symptom control is stable and no long-term indication remains.
- Escalate for dysphagia, bleeding, weight loss, progressive anemia, or persistent vomiting.
- Escalate if symptoms persist despite optimized adherence and timing.
References
Something out of date or unclear? Suggest an update. Leave out any patient details.